Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Angiolillo: Antiplatelet therapy in diabetes: efficacy and limitations of current treatment.... (0.09 sec) 

Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and …

- diabetesjournals.org
DJ Angiolillo - Diabetes Care, 2009 - Am Diabetes Assoc
Cardiovascular disease is the leading cause of morbidity and mortality in
patients with diabetes (1). The concomitant presence of multiple classical
cardiovascular risk factors in diabetic subjects contributes to enhanced ...
Cited by 3 - Related articles - All 4 versions

Facts and controversies of aspirin and clopidogrel therapy.

- prsjournal.com
DP Faxon, JE Freedman - American Heart Journal, 2009 - ccmjournal.org
Because of the central role of platelets in mediating ischemic events,
antiplatelet agents are critical components of atherothrombosis prevention.
Given their robust safety and efficacy profiles, aspirin and clopidogrel ...
Cited by 6 - Related articles - All 38 versions

The impact of bleeding in patients with acute coronary syndromes: how to optimize the …


D Fitchett - The Canadian journal of cardiology, 2007 - pubmedcentral.nih.gov
Recurrent ischemic events after an acute coronary syndrome (ACS) remain common.
Antithrombotic therapy with coronary revascularization reduces the frequency of
such life-threatening events. However, with the greater use of ...
Cited by 9 - Related articles - BL Direct - All 5 versions

Antiplatelet Therapy: Anti-Ischemic Benefits versus Bleeding Risk


CM GIBSON - Journal of interventional cardiology, 2008 - interscience.wiley.com
Balance between efficacy and safety is a major concern in therapeutic
interventions of patients with acute coronary syndromes. Identifying and
managing the risks that may negatively affect this balance can potentially ...
Cited by 2 - Related articles - All 5 versions

Defining a new standard for IVUS optimized drug eluting stent implantation: The PRAVIO …


RT Gerber, A Latib, A Ielasi, J Cosgrave, A … - … and cardiovascular interventions: official journal of …, 2008 - ncbi.nlm.nih.gov
OBJECTIVES:: Preliminary Investigation to the Angiographic Versus IVUS
Optimization Trial is a single center prospective observational intravascular
ultrasound (IVUS) guided stent implantation study assessing new criteria ...
Cited by 2 - Related articles

Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in …


G De Luca, E Cassetti, P Marino - Journal of Thrombosis and Thrombolysis, 2009 - Springer
Abstract Aims Recent concerns have emerged on the potential higher risk of stent
thrombosis after Drug-eluting stents (DES) implantation, that might be even more
pro- nounced among ST-segment elevation myocardial infarction (STEMI) ...
Cited by 2 - Related articles - All 2 versions

[CITATION] CYP2C19 genotypes in a population of healthy volunteers and in children with …


AE Sameer, GM Amany, AA Abdela, SA Fadel - Can J Clin Pharmacol, 2009
Cited by 2 - Related articles

Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute …


C Schmidt-Lucke, HP Schultheiss - Vascular Health and Risk Management, 2007 - pubmedcentral.nih.gov
Non-ST elevation acute coronary syndrome (NSTE-ACS) refers to a cardiovascular
disorder characterized by intracoronary thrombus formation on a disrupted
atherosclerotic plaque with partial or transient occlusion. Generation of ...
Cited by 3 - Related articles - BL Direct - All 7 versions

Intravenous low-molecular-weight heparins compared with unfractionated heparin in …

- posters2view.com [PDF] 
R Dumaine, M Borentain, O Bertel, C Bode, R … - Archives of Internal Medicine, 2007 - Am Med Assoc
Results Thirteen trials including 7318 patients met the inclusion criteria. A
total of 4201 patients (57.4%) received LMWH, and 3117 patients (42.6%) received
UFH. Intravenous LMWH use was associated with a significant reduction in ...
Cited by 3 - Related articles - BL Direct - All 5 versions

[CITATION] Investigators of Direct Stenting vs Optimal Angioplasty Trial (DIPOL), et al. Comparison of …


RJ Gil, T Pawłowski, D Dudek, G Horszczaruk, … - Am Heart J, 2007
Cited by 3 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google